Estimated Asian adult soy protein and isoflavone intakes

被引:363
作者
Messina, Mark
Nagata, Chisato
Wu, Anna H.
机构
[1] Nutr Matters Inc, Port Townsend, WA 98368 USA
[2] Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA
[3] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu 5011194, Japan
[4] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2006年 / 55卷 / 01期
关键词
D O I
10.1207/s15327914nc5501_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
There is substantial interest in the possible anticancer effects of soy foods. In part, this is because of the historically low incidence rates of breast and prostate cancer in Asia. Of the several putative soybean chemopreventive agents, isoflavones have received the most attention. Awareness of this research has led increasing numbers of consumers to use soy foods, isoflavone-fortified foods, and isoflavone supplements. Therefore, there is a need for guidance regarding appropriate isoflavone intake levels. To this end, this article analyzed soy protein (as a surrogate for isoflavones) and isoflavone intake of the major soy food-consuming countries using individual dietary surveys for the bulk of the information. In total, 24 surveys from 4 countries that met the inclusion criteria were identified: Japan (n = 11), China (n = 7), Hong Kong (h = 4), and Singapore (n = 2). The results indicate that older Japanese adults consume approximately 6-11 g of soy protein and 25-50 mg of isoflavones (expressed as aglycone equivalents) per day. Intake in Hong Kong and Singapore is lower than in Japan, whereas significant regional intake differences exist for China. Evidence suggests that <= 10% of the Asian population consumes as much as 25 g of soy protein or 100 mg of isoflavones per day. The applicability of these findings for making soy intake recommendations for non-Asians is discussed.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 120 条
[1]
Phytoestrogens and breast cancer [J].
Adlercreutz, H .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 83 (1-5) :113-118
[2]
Ajiki W, 2004, JPN J CLIN ONCOL, V34, P352, DOI 10.1093/jjco/hyh056
[3]
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[4]
ALDERCREUTZ H, 1991, AM J CLIN NUTR, V54, P1093
[5]
Soy processing influences growth of estrogen-dependent breast cancer tumors [J].
Allred, CD ;
Allred, KF ;
Ju, YH ;
Goeppinger, TS ;
Doerge, DR ;
Helferich, WG .
CARCINOGENESIS, 2004, 25 (09) :1649-1657
[6]
Allred CD, 2001, CANCER RES, V61, P5045
[7]
Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens [J].
An, JP ;
Tzagarakis-Foster, C ;
Scharschmidt, TC ;
Lomri, N ;
Leitman, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :17808-17814
[8]
Arai Y, 2000, J Epidemiol, V10, P127
[9]
Arai Y, 2000, J NUTR, V130, P2243
[10]
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women [J].
Bloedon, LT ;
Jeffcoat, AR ;
Lopaczynski, W ;
Schell, MJ ;
Black, TM ;
Dix, KJ ;
Thomas, BF ;
Albright, C ;
Busby, MG ;
Crowell, JA ;
Zeisel, SH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (05) :1126-1137